Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as $4.61 and last traded at $4.90, with a volume of 5224 shares trading hands. The stock had previously closed at $4.93.
Hypera Price Performance
The company has a market capitalization of $3.10 billion, a P/E ratio of 9.18 and a beta of 1.04. The company’s 50-day moving average price is $5.21 and its two-hundred day moving average price is $5.55.
Hypera (OTCMKTS:HYPMY – Get Free Report) last released its quarterly earnings results on Thursday, July 25th. The company reported $0.15 earnings per share for the quarter. The business had revenue of $420.00 million during the quarter.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- Stock Sentiment Analysis: How it Works
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to invest in marijuana stocks in 7 steps
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Use the MarketBeat Dividend Calculator
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
